Insigneo Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Insigneo Advisory Services's BMY Position: Q2 2026 in Review
Insigneo Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,590 shares — an estimated $278K sold.
Insigneo Advisory Services first reported a position in BMY in Q4 2023 and held it in 8 quarters. The position peaked at $1.31M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Insigneo Advisory Services reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Insigneo Advisory Services sold 4,590 Bristol-Myers Squibb shares in Q2 2026, an estimated $278K.
- Insigneo Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 8 quarters.
- Insigneo Advisory Services's Bristol-Myers Squibb position peaked at $1.31M in Q1 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.